Dr. Sajad Zalzala, MD
Co-founder & Chief Medical Officer
Dr. Sajad Zalzala turned his passion for disease prevention and longevity into a decades-long career. Leveraging his experience guiding multiple healthcare startups to success, Dr. Z co-founded AgelessRx with a vision to build a platform for all things longevity and positively impact the lives of as many people as possible.
Dr. Z received his medical degree from Wayne State University, and licensed to practice medicine in all 50 States and Washington D.C. Deeply committed to advancing longevity science, Dr. Z has led several critical studies that have helped confirm the effects of healthspan-enhancing medications in humans, including serving as the Clinical Investigator for the groundbreaking PEARL trial, the world’s first and largest trial of Rapamycin for aging in humans.
He is an active member of the International College of Integrated Medicine, where he has chaired two international conferences and formerly served on the board. Dr. Z’s vision for AgelessRx is for it to be the go-to platform for all things longevity, to positively impact the lives of as many people as possible.
Featured in:
From the desk of Dr. Z
-
What Is Microdosing Semaglutide?
From the Desk of Dr. Z: AgelessRx Co-founder and Chief Medical Officer, Dr. Sajad Zalzala offers his insightful perspective on topics related to longevity. With a wealth of experience and … Continue reading “What Is Microdosing Semaglutide?”
-
Combining LDN with Microdosing Semaglutide
From the Desk of Dr. Z: AgelessRx Co-founder and Chief Medical Officer, Dr. Sajad Zalzala, offers his insightful perspective on topics related to longevity. With a wealth of experience and … Continue reading “Combining LDN with Microdosing Semaglutide”
-
How to Microdose with Semaglutide
From the Desk of Dr. Z: AgelessRx Co-founder and Chief Medical Officer, Dr. Sajad Zalzala, offers his insightful perspective on topics related to longevity. With a wealth of experience and … Continue reading “How to Microdose with Semaglutide”